BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 29961247)

  • 21. Safety of testosterone therapy in men with prostate cancer.
    Morgentaler A; Caliber M
    Expert Opin Drug Saf; 2019 Nov; 18(11):1065-1076. PubMed ID: 31495240
    [No Abstract]   [Full Text] [Related]  

  • 22. Controversies with testosterone therapy.
    Khera M
    Can J Urol; 2020 Aug; 27(S3):20-23. PubMed ID: 32875998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testosterone replacement therapy in the setting of prostate cancer treated with radiation.
    Pastuszak AW; Pearlman AM; Godoy G; Miles BJ; Lipshultz LI; Khera M
    Int J Impot Res; 2013 Jan; 25(1):24-8. PubMed ID: 22971614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer: Testosterone therapy for hypogonadal men with prostate cancer.
    Catarinicchia SP; Crawford ED
    Nat Rev Urol; 2016 Sep; 13(9):497-8. PubMed ID: 27431338
    [No Abstract]   [Full Text] [Related]  

  • 25. Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia.
    Rhoden EL; Morgentaler A
    J Urol; 2003 Dec; 170(6 Pt 1):2348-51. PubMed ID: 14634413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer.
    Pastuszak AW; Khanna A; Badhiwala N; Morgentaler A; Hult M; Conners WP; Sarosdy MF; Yang C; Carrion R; Lipshultz LI; Khera M
    J Urol; 2015 Nov; 194(5):1271-6. PubMed ID: 26025500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does testosterone therapy increase the risk of prostate cancer?
    Dobs AS; Morgentaler A
    Endocr Pract; 2008 Oct; 14(7):904-11. PubMed ID: 18996823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen replacement in men undergoing treatment for prostate cancer.
    Rhoden EL; Averbeck MA; Teloken PE
    J Sex Med; 2008 Sep; 5(9):2202-8. PubMed ID: 18638000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testosterone replacement therapy and prostate cancer: a word of caution.
    Brand TC; Canby-Hagino E; Thompson IM
    Curr Urol Rep; 2007 May; 8(3):185-9. PubMed ID: 17459266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testosterone replacement therapy after primary treatment for prostate cancer.
    Agarwal PK; Oefelein MG
    J Urol; 2005 Feb; 173(2):533-6. PubMed ID: 15643240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Testosterone replacement therapy and prostate cancer. The current position 67 years after the Huggins myth].
    Rinnab L; Gust K; Hautmann RE; Küfer R
    Urologe A; 2009 May; 48(5):516-22. PubMed ID: 19296069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrence of prostate cancer in patients receiving testosterone supplementation for hypogonadism.
    Gray H; Seltzer J; Talbert RL
    Am J Health Syst Pharm; 2015 Apr; 72(7):536-41. PubMed ID: 25788507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Voiding function improves under long-term testosterone treatment (TTh) in hypogonadal men, independent of prostate size.
    Yassin A; Alwani M; Al-Zoubi RM; Aboumarzouk OM; Talib R; Nettleship J; Kelly D; Albaba B
    Int Urol Nephrol; 2023 Jul; 55(7):1649-1658. PubMed ID: 37148486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Testosterone and the prostate].
    Sperling H; Rossi R; Lümmen G; Rübben H
    Urologe A; 2004 Sep; 43(9):1092-6. PubMed ID: 15368045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone replacement in prostate cancer survivors with hypogonadal symptoms.
    Leibowitz RL; Dorff TB; Tucker S; Symanowski J; Vogelzang NJ
    BJU Int; 2010 May; 105(10):1397-401. PubMed ID: 19912179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testosterone replacement therapy in men with prostate cancer: a time-varying analysis.
    Kaplan AL; Lenis AT; Shah A; Rajfer J; Hu JC
    J Sex Med; 2015 Feb; 12(2):374-80. PubMed ID: 25496237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of testosterone administration to men with prostate cancer is unpredictable: a word of caution and suggestions for a registry.
    Morales A
    BJU Int; 2011 May; 107(9):1369-73. PubMed ID: 21518230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there a protective role of testosterone against high-grade prostate cancer? Incidence and severity of prostate cancer in 553 patients who underwent prostate biopsy: a prospective data register.
    Yassin A; Salman M; Talib RA; Yassin DJ
    Aging Male; 2017 Jun; 20(2):125-133. PubMed ID: 28282997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between total testosterone levels and prostate cancer: a review of the continuing controversy.
    Klap J; Schmid M; Loughlin KR
    J Urol; 2015 Feb; 193(2):403-13. PubMed ID: 25260832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.